title: Novel Therapies for the Treatment of Central Sleep Apnea.
abstract: Neurophysiologically, central apnea is due to a temporary cessation of respiratory rhythmogenesis in medullary respiratory networks. Central apneas occur in several disorders and result in pathophysiological consequences, including arousals and desaturation. The 2 most common causes in adults are congestive heart failure and chronic use of opioids to treat pain. Under such circumstances, diagnosis and treatment of central sleep apnea may improve quality of life, morbidity, and mortality. This article discusses recent developments in the treatment of central sleep apnea in heart failure and opioids use.
authors.affiliation: Bethesda North Hospital, 10535 Montgomery Road, Suite 200, Cincinnati, OH 45242, USA. Electronic address: shahrokhjavaheri@icloud.com.
authors.forename: Shahrokh
authors.initials: S
authors.lastname: Javaheri
authors.affiliation: Section of Cardiology, University of Oklahoma College of Medicine, Oklahoma City, OK, USA.
authors.forename: Robin
authors.initials: R
authors.lastname: Germany
authors.affiliation: University of Alberta, Edmonton, Alberta, Canada.
authors.forename: John J
authors.initials: JJ
authors.lastname: Greer
mesh_terms: D006801:Humans; D020182:Sleep Apnea, Central / Q000628:therapy*
keywords: Adaptive servo ventilators; Ampakines; Apnea; CPAP; Congestive heart failure; Opioids